| Previous close | 200.24 |
| Open | 199.69 |
| Bid | 180.00 x 100 |
| Ask | 219.93 x 100 |
| Day's range | 199.69 - 201.94 |
| 52-week range | 119.37 - 214.34 |
| Volume | 986,743 |
| Avg. volume | 936,066 |
| Market cap | 29.41B |
| Beta | 0.90 |
| PE ratio (TTM) | 40.41 |
| EPS (TTM) | 4.98 |
| Earnings date | 30 Oct 2017 - 3 Nov 2017 |
| Dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 186.21 |
- Simply Wall St.•21 hours ago
Is It Time To Buy Illumina Inc (ILMN)?
Today we’re going to take a look at the well-established Illumina Inc (NASDAQ:ILMN). The company’s stock saw a double-digit share price rise of over 10% in the past couple ofRead More...
- Motley Fool•2 days ago
These 3 Stocks Are Priced for Perfection. Can They Deliver?
Exelixis, Illumina, and Veeva Systems. Expensive, but worth it?
Markit•3 days agoSee what the IHS Markit Score report has to say about Illumina Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
